Skip to main content
. 2025 Nov 15;13(11):1164. doi: 10.3390/vaccines13111164
ADCC Antibody-dependent cellular cytotoxicity
AI Artificial intelligence
CDC Complement-dependent cytolysis
COBRA Computationally optimized broadly reactive antigen
CTLs Cytotoxic T lymphocytes
HA Hemagglutinin
IAVs Influenza A viruses
IIV3 Inactivated influenza vaccines
LAIV3 Live-attenuated influenza vaccine
LNPs Lipid nanoparticles
M1 Matrix protein
M2e M2 extracellular domain
MHC Major histocompatibility complex
MPLA Monophosphoryl lipid A
MVA Modified Ankara
NP Nucleoprotein
PB1 Polymerase basic protein 1
PEG Polyethylene glycol
PLGA Poly lactic-co-glycolic acid
PROTAC Proteolysis-targeting chimeric
PROTAR Proteolysis-targeting
RIV3 Recombinant influenza vaccine
saRNA Self-amplifying RNA
TLR Toll-like receptor
vRNA Viral RNA